Health Bulletin 05/ March/ 2024

Published On 2024-03-05 12:03 GMT   |   Update On 2024-03-06 12:03 GMT

Here are the top health news for the day:

Dr Harsh Vardhan's retirement from politics: Returning to his roots in ENT

After a long political career of 30 years, the former Union Health Minister Dr. Harsh Vardhan has announced his decision to quit electoral politics.

In an X post, Dr Harsh Vardhan mentioned that he has promises to keep and announced his decision to go back to his ENT Clinic at Krishna Nagar. He further mentioned that he would continue to pursue his work against tobacco and substance abuse, against climate change as well as teaching simple and sustainable lifestyles.

For more information click on the link below:


Delhi High Court halts pharma giant's legal threats over 'ELDER' trademark dispute

In a significant legal development in New Delhi, the Delhi High Court issued an interim order restraining Mumbai-based Elder Projects from threatening Antex Pharma over the 'ELDER' and 'ELDERVIT' trademarks. Antex Pharma argued that their extensive use of these trademarks for pharmaceutical products has garnered significant goodwill, while Elder Projects allegedly made baseless legal threats to assert rights over them. The court's decision reflects a cautious approach, balancing the protection of Antex Pharma from intimidation tactics with the recognition that ownership of the 'ELDER' trademark belongs to Elder Pharmaceuticals Ltd., as confirmed by a 2019 judgment. This ruling nullifies Elder Projects' claims. The interim order not only provides temporary relief to Antex Pharma but also signals the court's acknowledgment of the importance of fair competition and protecting established trademarks in the pharmaceutical industry. As the case progresses, it will have implications for trademark law and corporate practices in India's pharmaceutical sector, showcasing the judiciary's role in navigating trademark disputes.

Advertisement


AIIMS Director: "Artificial Intelligence will forever serve us; we retain control"
Artificial Intelligence is always going to be artificial and the humans will remain the masters, Director AIIMS Delhi, Dr M Srinivas said on Thursday while outlining how the premier medical institute in the national capital is harnessing AI for the benefit of patients, including in cancer treatment.

Participating in 'ANI Dialogues - Navigating India's Health Sector' here, Dr Srinivas said AI complements and supplements efforts and allows scalability and filtering at a faster pace.

For more information click on the link below:


Lancet study exposes India's dual nutritional crisis: From undernutrition to obesity
The recent Lancet study sheds light on India's significant nutritional transition, revealing the dual challenges of undernutrition and obesity. Nutritionists attribute this "double whammy" to factors such as inadequate consumption of nutritious foods and the easy availability of cheap, unhealthy alternatives. 
Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News